Iscalimab | Interleukin Related interleukin-related.com

Product Name :
Iscalimab

Search keywords :
Iscalimab

drugId :
null

Target Vo:
Tumor necrosis factor receptor superfamily member 5

Target Vo Short Name :
CD40

Moa_Name:
Tumor necrosis factor receptor superfamily member 5 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
China Novartis Institutes For Biomedical Research Co Ltd

Active Indication_Name:
Sjogren’s Syndrome

In Active Indication_Name:
Myasthenia Gravis

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Blinatumomab Protocol
Androgen receptor Rabbit mAb References
NLRP3 Antibody: NLRP3 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 118 kDa, targeting to NLRP3. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Mouse, Rat.

Author: Interleukin Related

Related Posts